Riskpilot← Back to searchSign inGet full accessBYENS BANDAGIST ApS
APSActiveCVR 21767700Jyllandsgade 10Manufacture of medical and dental instruments and supplies · NACE 3250Est. 19994 employees
Revenue 2025
DKK 2,1M
+19% vs 2024
EBITDA margin
13.8%
+425% vs 2024
Equity ratio
55.8%
Financial strength
Net profit 2025
DKK 250K
+322% vs 2024
| Revenue | DKK 2,1M | +19% |
| EBITDA | DKK 283K | +425% |
| Net profit | DKK 250K | +322% |
| Total assets | DKK 2,1M | +8% |
| Equity | DKK 1,2M | +28% |
| Employees | 4 | — |
Legal name
BYENS BANDAGIST ApS
CVR number
21767700
Legal form
Anpartsselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
22. juni 1999
Share capital
DKK 245.000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et bestyrelsesmedlem i forening med en direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive handels- og produktionsvirksomhed.
Address
Jyllandsgade 10
Phone
+4597215657
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2.526 | 1.603 | 1.703 | 1.727 | 2.059 |
| Staff expenses | -1.843 | -1.736 | -1.799 | -1.815 | -1.776 |
| EBITDA | 683 | -132 | -96 | -87 | 283 |
| Depreciation & amort. | -22 | -26 | -24 | -12 | -8 |
| EBIT | 661 | -158 | -119 | -100 | 275 |
| Net financials | -7 | -19 | -29 | -13 | -25 |
| Profit before tax | 654 | -177 | -148 | -113 | 250 |
| Tax | 144 | -0 | -0 | -0 | -0 |
| Net profit | 510 | -177 | -148 | -113 | 250 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3.019 | 2.090 | 2.160 | 1.925 | 2.074 |
| Equity | 1.746 | 1.168 | 1.020 | 908 | 1.158 |
| Long-term debt | 0 | 0 | 481 | 225 | 82 |
| Short-term debt | 1.273 | 922 | 659 | 792 | 835 |
| Total debt | 1.273 | 922 | 1.139 | 1.017 | 916 |
EBITDA margin
13.8%
This company
15.8%
Market median
-13% vs market
20212025
Equity ratio
55.8%
This company
38.2%
Market median
+46% vs market
20212025
Return on equity
21.6%
This company
18.4%
Market median
+17% vs market
20212025
Net profit margin
12.2%
This company
8.1%
Market median
+51% vs market
20212025
Asset turnover
0.99×
This company
1.12×
Market median
+12% vs market
20212025
Debt / equity
0.79×
This company
0.62×
Market median
+27% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HB Management | Management | 2016 |
GP Founder | Founder | 1999 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 1999 | |
| Board of Directors | 1999 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2018 | |
| Company | 50–66.65% | 50–66.65% | 2002 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BROGAARD HOLDING RANDERS ApS
BYENS BANDAGIST ApS Board members of BYENS BANDAGIST ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Helle Brogaard | Management | 0 companies |
| Gunnar Poulsen Nielsen | Founder | 0 companies |
| Claus Brogaard | Board of Directors | 0 companies |
| Aase Brita Nielsen | Board of Directors | 0 companies |